Skip to content

Univation XM France

A Prospective, Observational, Monocentre 5-year Follow-up Clinical Trial on a Historical Consecutive Cohort of Unicompartmental Knee Arthroplasty Patients Treated With the Mobile Bearing Unicondylar Knee Prosthesis Univation XM

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04199481
Enrollment
0
Registered
2019-12-16
Start date
2020-08-31
Completion date
2023-08-31
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Knee, Osteoarthritis, Knee, Osteoarthrosis of Knee, Unicompartmental Knee Arthroplasty

Keywords

unicompartmental knee arthroplasty, retrospective study, Knee Society Score

Brief summary

The study is set up due to regulatory purposes and to collect routine clinical data of the mobile-bearing implant univation XM. The study is designed as a prospective follow-up study with a historic patient cohort who have been treated with the product under investigation two years ago. This design is selected to quicker realize follow-up data as patients have already been treated in the past. As the mobile version of the implant is not widely used, the study will be set up as a monocentric study in France. The clinical hypothesis of the study is that patients who are treated with the product under investigation have a similar outcome and survival rate in comparison to other established unicondylar knee systems on the market. Comparison for the later evaluation will be taken out of recent orthopaedic registries.

Interventions

None listed

Sponsors

B. Braun Medical SA
CollaboratorINDUSTRY
Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has received a primary mobile bearing UKA at the study site between January 2017 and December 2018 using the product under investigation * Patient's written consent and willingness to participate at the clinical study and the follow-up examinations

Exclusion criteria

* Pregnancy * Patient Age \<18 years at the time of the surgery

Design outcomes

Primary

MeasureTime frameDescription
Survival Rate of the Implant5 years after surgeryRevision-free survival rate after 5 years according to Kaplan-Meier

Secondary

MeasureTime frameDescription
Development of Knee joint functionin the postoperative course, up to 5 years after surgeryPostoperative Development of knee joint function measured with the Knee Society Score (KSS). The KSS is composed of two subgroups Knee Score and Function Score; both parts have a maximum score of 100, where higher values represent better results.
Development of Oxford Knee Scorein the postoperative course, up to 5 years after surgeryA patient-reported outcome instrument which contains 12 questions on activities of daily living that assess function and residual pain in patients undergoing total knee replacement (TKR) arthroplasty. Oxford Knee Score has a maximum of 48 points indicating satisfactory knee function
Intraoperative/surgery DataintraoperativeSurgical and intraoperative data collected will include the date and duration of the surgery, selected implants and sizes, blood loss and implant descriptions. Surgical duration is to be measured from the time of incision to the time of skin closure, skin-to-skin. All potential Adverse Events will be collected during the surgical procedure and/or from the surgical record and will be documented on the intra-operative Evaluation Form.
Radiographic evaluationin the postoperative course, up to 5 years after surgeryThe outcome and function of a knee prosthesis is influenced by the postoperative alignment of the leg and the orientation in reference to the axis. Incorrect positioning can lead to an increased implant wear and functional limitations; The aim of a postoperative alignment within 3° varus to 3° valgus will be assessed using long leg x-rays up to 5 years after surgery
Rate of Serious Adverse Eventsin the postoperative course, up to 5 years after surgeryAs part of the follow-up examination, any upcoming (serious) adverse device events or effects related or not related to the product under investigation, will be documented in the dedicated Case Report Forms. Recorded complications will be categorized and analyzed in order to assess the safety of the univation XM prosthesis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026